Stay updated on Safety of CHF6523 in COPD: Clinical Trial
Sign up to get notified when there's something new on the Safety of CHF6523 in COPD: Clinical Trial page.

Latest updates to the Safety of CHF6523 in COPD: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to reflect a new version of the study protocol (v2.15.0) and includes the EudraCT number for the study. Additionally, the study's design has been simplified, focusing on the safety and pharmacokinetics of CHF6523 in healthy volunteers and COPD patients.SummaryDifference45%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 13, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.4%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check80 days agoChange DetectedThe webpage has updated its date references, removing older dates and adding new ones for February 2025. This indicates a refresh of the content to reflect more current information.SummaryDifference0.9%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to Safety of CHF6523 in COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CHF6523 in COPD: Clinical Trial page.